Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYVE.L Regulatory News (HYVE)

  • There is currently no data for HYVE

Additional Listing

3 Aug 2017 07:00

RNS Number : 9554M
ITE Group PLC
03 August 2017
 

3 August 2017

 

ITE Group plc (the 'Company')

Additional Listing

 

The Company confirms the allotment and issue of 444,289 ordinary shares of 1 pence each ('Shares'), at a price of 154.35 pence per Share, to shareholders who are participants in the Company's Scrip Dividend Scheme (the 'Scheme') in respect of the interim dividend for the year ending 30 September 2017 payable on 3 August 2017. This represents approximately 0.17 per cent of the current issued share capital of the Company. The Shares rank equally with existing issued ordinary shares. The Company holds no shares in treasury.

 

Application has been made to the Financial Conduct Authority for the Shares to be admitted to the Official List and to the London Stock Exchange for the Shares to be admitted to trading. Dealings in the Shares are expected to commence on 4 August 2017.

 

Following admission, the issued capital of the Company will comprise 269,280,274 Shares.

The total number of voting rights in ITE Group plc is therefore 269,280,274. This figure should be used by shareholders as the denominator for the calculations by which they determine whether they are required to notify their interest in, or a change to their interest in ITE Group plc, under the Disclosures and Transparency Rules.

 

Contact:

Anneka Kingan, Group Company Secretary

Anneka.kingan@ite-exhibitions.com

+44 (0) 20 7596 5139

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ALSUUUNRBOAWRAR
Date   Source Headline
13th Jul 20177:01 amRNSDirectorate Change
13th Jul 20177:00 amRNSTrading Statement
21st Jun 20172:31 pmRNSDirector/PDMR Shareholding
16th Jun 201712:02 pmRNSPrice Monitoring Extension
15th Jun 20177:00 amRNSScrip Reference Price
8th Jun 20172:04 pmRNSHolding(s) in Company
31st May 201710:00 amRNSTotal Voting Rights
25th May 20177:00 amRNSRemaining 25% stake in Africa Oil Week
22nd May 20173:48 pmRNSHolding(s) in Company
17th May 20173:25 pmRNSInterim Dividend Arrangements
16th May 20177:00 amRNSInterim Results & Strategy Update
7th Apr 20179:18 amRNSHolding(s) in Company
7th Apr 20179:11 amRNSHolding(s) in Company
4th Apr 20177:00 amRNSTrading Update
3rd Apr 20172:46 pmRNSHolding(s) in Company
3rd Apr 20179:43 amRNSBlock listing Interim Review
15th Mar 20179:08 amRNSHolding(s) in Company
1st Mar 20172:10 pmRNSHolding(s) in Company
28th Feb 20177:00 amRNSTotal Voting Rights
27th Feb 20177:00 amRNSHolding(s) in Company
8th Feb 20179:14 amRNSHolding(s) in Company
6th Feb 20179:00 amRNSAdditional Listing
26th Jan 20171:24 pmRNSResult of AGM
26th Jan 20177:00 amRNSTrading Update
20th Jan 20178:30 amRNSHolding(s) in Company
6th Jan 20173:02 pmRNSSCRIP Reference Share Price
30th Dec 201610:00 amRNSTotal Voting Rights
19th Dec 20162:49 pmRNSNotice of AGM
9th Dec 20161:31 pmRNSCompletion of 70% Stake in Shanghai Gehua
29th Nov 20167:00 amRNSPreliminary Results
9th Nov 20167:00 amRNSHolding(s) in Company
7th Nov 20169:09 amRNSHolding(s) in Company
31st Oct 20168:55 amRNSHolding(s) in Company
17th Oct 20169:43 amRNSHolding(s) in Company
4th Oct 20162:14 pmRNSBlock listing Interim Review
3rd Oct 20167:00 amRNSPre-close Trading Update
22nd Sep 20165:45 pmRNSHolding(s) in Company
9th Sep 201612:30 pmRNSUpdate on Appointment of new CFO
1st Sep 201611:19 amRNSTotal Voting Rights
1st Sep 20167:00 amRNSBoard Change
19th Aug 201610:01 amRNSHolding(s) in Company
17th Aug 201610:51 amRNSHolding(s) in Company
8th Aug 20169:34 amRNSHolding(s) in Company
5th Aug 201611:19 amRNSAdditional Listing
21st Jul 20162:56 pmRNSHolding(s) in Company
19th Jul 20167:00 amRNSAppointment of Chief Financial Officer
12th Jul 20167:00 amRNSInterim Management Statement
28th Jun 20164:20 pmRNSHolding(s) in Company
16th Jun 20162:46 pmRNSScrip Reference Share Price
7th Jun 20169:58 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.